0.47
price down icon0.84%   -0.004
after-market Handel nachbörslich: .50 0.03 +6.38%
loading

Finanzdaten der Bioatla Inc-Aktie (BCAB)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
14.29%
24.46
28.54 35.02 37.20 28.93
Operating Income/Loss
14.29%
-24.46
-28.54 -35.02 -37.20 -28.93
Income/Loss From Continuing Operations Before Tax
13.71%
-23.23
-26.93 -33.33 -35.75 -27.46
Income/Loss From Continuing Operations After Tax
13.71%
-23.23
-26.93 -33.33 -35.75 -27.46
Net Income/Loss
13.71%
-23.23
-26.93 -33.33 -35.75 -27.46
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
68,294%
48.09
0.0703 47.83 47.71 47.58
Diluted Average Shares
68,294%
48.09
0.0703 47.83 47.71 47.58
Basic Earnings Per Share
14.29%
-0.48
-0.56 -0.70 -0.75 -0.58
Diluted Earnings Per Share
14.29%
-0.48
-0.56 -0.70 -0.75 -0.58
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$39.42
price down icon 3.95%
$351.17
price down icon 0.32%
$21.50
price down icon 3.85%
$5.30
price down icon 2.03%
biotechnology ONC
$224.99
price down icon 0.84%
$123.77
price up icon 2.39%
Kapitalisierung:     |  Volumen (24h):